S100A4 and acute myeloid leukemia: Some studies have also shown that bone marrow mesenchymal stem cell-derived exosomes (BM-MSC-exos) can upregulate the expression of S100A4 to promote the proliferation of acute myeloid leukemia (AML) cells and enhance the resistance of AML cells to cytarabine [4].